|
ZBTB39 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.727960E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.060600E-03 |
| Normal-vs-Stage2 |
2.768200E-01 |
| Normal-vs-Stage3 |
1.470970E-01 |
| Normal-vs-Stage4 |
1.062840E-01 |
| Stage1-vs-Stage2 |
4.231200E-01 |
| Stage1-vs-Stage3 |
4.819600E-01 |
| Stage1-vs-Stage4 |
9.639200E-01 |
| Stage2-vs-Stage3 |
8.693600E-01 |
| Stage2-vs-Stage4 |
6.082000E-01 |
| Stage3-vs-Stage4 |
6.524000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.090170E-02 |
| Normal-vs-AfricanAmerican |
1.149160E-01 |
| Normal-vs-Asian |
3.173700E-02 |
| Caucasian-vs-AfricanAmerican |
5.608400E-01 |
| Caucasian-vs-Asian |
4.887800E-01 |
| AfricanAmerican-vs-Asian |
3.831600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.476700E-03 |
| Normal-vs-Female |
8.153600E-01 |
| Male-vs-Female |
8.776700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.362200E-02 |
| Normal-vs-Extreme_Weight |
7.227700E-04 |
| Normal-vs-Obese |
2.544400E-01 |
| Normal-vs-Extreme_Obese |
1.442070E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.898030E-01 |
| Normal_Weight-vs-Obese |
3.853600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.073900E-02 |
| Extreme_Weight-vs-Obese |
1.238390E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.569400E-01 |
| Obese-vs-Extreme_Obese |
6.619800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.585800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.639380E-01 |
| Normal-vs-Age(61-80Yrs) |
1.921520E-03 |
| Normal-vs-Age(81-100Yrs) |
2.075200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.325200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.562000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.232410E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.627700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.243800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.162000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.527700E-02 |
| Normal-VS-Type2 PRCC |
6.15829999999207E-05 |
| Normal-VS-KIRP CIMP |
7.294600E-01 |
| Normal-VS-Unclassified PRCC |
9.550800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.175000E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.415050E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.337950E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.836400E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.335400E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
7.892600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.30489999999417E-05 |
| Normal-vs-N1 |
5.591600E-01 |
| Normal-vs-N2 |
1.183380E-01 |
| N0-vs-N1 |
2.980500E-03 |
| N0-vs-N2 |
7.741800E-01 |
| N1-vs-N2 |
2.403800E-01 |
|
|
